Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Maca Root: The Definitive Guide

Why a self-reported sexual-health signal is different from raising testosterone or proving one maca colour is best.

A source-first maca snapshot. It does not show that maca raises hormones, treats sexual dysfunction or works the same across preparations.
Published by DoserlyUpdated Next scheduled review: January 202714 min readHow this guide was made
In this guide

What is maca root?

Maca is Lepidium meyenii, a Brassicaceae plant traditionally cultivated in the Andes. The used part is a swollen hypocotyl, often described on labels as a root. Health Canada's current monograph covers oral dried hypocotyl or root material and does not make every extract equivalent. [1]

Commercial forms include dry powder, heat-processed or “gelatinized” powder, tablets and extracts. Gelatinization refers to processing the starch-rich material; it is not a guarantee of stronger clinical effects. A label should identify the species, plant part, preparation and amount rather than relying on “Peruvian ginseng,” because maca is not a Panax ginseng.

Maca contains macamides, glucosinolates, sterols and other constituents. These are useful for describing chemistry, but no marker alone proves that a product reproduces a study or improves sexual function.

Typical Maca Protocols

Oral use · every row keeps population, preparation, amount and outcome together. Trial and licensing schedules are not recommendations. [1], [2], [4], [5], [6]
Source and populationPreparationAmount each timeFrequencyDurationMeasured outcomes
Gonzales 2002 · 57 healthy men aged 21–56Gelatinized maca1.5 g or 3 g total daily assignmentDaily; division not stated in the abstract12 weeksSelf-reported sexual desire and depression/anxiety scores
Desire improved from week 8; the abstract does not establish an immediate effect or clinical treatment.
Dording 2008 · 20 people with antidepressant-associated sexual dysfunctionMaca1.5 g or 3 g total daily assignmentDaily; division not stated in the abstract12 weeksASEX and MGH-SFQ sexual-function scales
Dose-comparison pilot with no placebo group; 16 participants were included in intent-to-treat analysis and 10 completed.
Dording 2015 · 45 women with SSRI/SNRI-associated sexual dysfunctionMaca root1.5 gTwice daily · 3 g/day total12 weeksASEX and MGH-SFQ mean changes and remission thresholds
42 women entered modified intent-to-treat analysis. Mean score changes did not differ significantly overall or within menopausal subgroups; remission counts were very small.
Gonzales-Arimborgo 2016 · 175 adults at low or high altitudeBlack maca, red maca or placebo3 g totalDaily12 weeksSelf-perceived mood, energy, health status and chronic mountain-sickness measures
The study does not establish a general rule that one colour is best for a sex or condition.
Health Canada 2024 monograph · eligible licensed productsDried hypocotyl/rootProduct-specificDaily total 2–3.5 g for menopausal mood claims or 3–3.5 g for sexual-health claimsProfessional review beyond stated limitsLicensing claims and required cautions
A regulatory monograph is not a randomized trial and does not prescribe an individual regimen.

There is no RDA, AI or UL for maca. Health Canada's amounts apply to eligible licensed products and claims. Its duration wording calls for professional review beyond three months at 0.6–3 g/day and beyond six weeks above 3 g/day. Lack of a nutrient UL does not mean unrestricted use. [1]

Titration
The selected trials assigned fixed daily totals. They do not establish a standard step-up schedule.
Timing
Abstracts often report only the daily total. Do not invent a morning, meal or divided-dose schedule when the source does not report one.
Duration
Most selected efficacy studies lasted 12 weeks. That is a research duration, not a guaranteed onset or a long-term safety boundary.
Stopping
No evidence-based taper is established. Stop and seek review for allergy, persistent digestive symptoms, insomnia, marked mood change or a concerning medicine or laboratory issue.
Whole powder, gelatinized material and extracts can differ. Match a claim to the preparation actually studied instead of comparing milligrams alone. Sources: Health Canada maca monograph.

What is maca commonly used for?

Maca is marketed for sexual desire, antidepressant-associated sexual dysfunction, menopausal symptoms, fertility, energy, mood and testosterone. Human evidence is most directly relevant to self-reported sexual outcomes, and even there the studies are small, older and preparation-specific. A 2010 systematic review found limited evidence rather than a settled treatment effect. [11]

The healthy-men study is often retold as a testosterone result. It was not: sexual desire improved on a questionnaire, while a companion hormone report found no group difference in measured reproductive hormones. [2], [3]

Claims for fertility, athletic performance, prostate health, cognition or a colour-specific effect rely heavily on small studies, surrogate outcomes or preclinical work. They should not be presented as established clinical benefits.

Which form and label details matter?

Read the label in this order:

  1. Species: Lepidium meyenii rather than only “maca” or “Peruvian ginseng.”
  2. Plant part: hypocotyl/root, not an unspecified whole plant.
  3. Preparation: dry powder, gelatinized powder or extract.
  4. Amount basis: actual material per serving and daily total; an extract ratio does not automatically convert to a trial dose.
  5. Colour: black, red or yellow can describe phenotype, but colour marketing does not prove a clinical advantage.
  6. Other ingredients: stimulants, sexual-health blends or hormones make outcomes and adverse effects harder to attribute.

“Gelatinized” means heat and moisture were used to alter the starch matrix. It does not mean pharmaceutical gelatin was added, and it does not by itself establish better absorption or efficacy.

What does the human evidence show?

Sexual desire in healthy men

Fifty-seven healthy men were randomized to gelatinized maca at 1.5 g/day, 3 g/day or placebo for 12 weeks. Self-reported sexual desire differed from placebo from week 8, while depression and anxiety scores did not explain the signal. The study was small and measured desire rather than erectile function, fertility or a diagnosed disorder. [2]

A companion analysis found no treatment effect on testosterone, estradiol, LH, FSH, prolactin or 17-hydroxyprogesterone. The pair of papers supports separating perceived desire from serum hormone change. [3]

Antidepressant-associated sexual dysfunction

The 2008 dose-finding pilot enrolled 20 remitted depressed outpatients taking antidepressants. It compared 1.5 g/day with 3 g/day for 12 weeks, without a placebo group. Only 10 completed the study; 16 contributed to intent-to-treat analysis. The higher-dose group had within-group improvement on sexual-function scales, but attrition, size and lack of placebo make this a preliminary signal. [4]

In 2015, 45 women taking an SSRI or SNRI were randomized to 1.5 g maca root twice daily or placebo twice daily for 12 weeks; 42 entered modified intent-to-treat analysis. Mean changes in total ASEX and MGH-SFQ scores were not significantly different between groups, either overall or within premenopausal or postmenopausal subgroups. Remission counts were numerically higher with maca on several thresholds, but involved very few people and extremely wide confidence intervals; the postmenopausal subgroup contained only 12 women. Medication-associated sexual dysfunction should be reviewed with the prescriber rather than managed by changing antidepressants independently. [5]

Black and red maca

A 12-week trial randomized 175 adults living at low or high altitude to 3 g/day black maca, red maca or placebo. It reported changes in self-perceived mood, energy and health-related measures. The altitude strata, self-reported outcomes and specific products limit transfer. It does not validate marketing rules such as “black for men” or “red for women.” [6]

Menopause and other claims

A 2011 systematic review found the menopausal evidence limited by few, small trials and uncertain risk of bias. Fertility, sport, prostate and cognitive claims remain too product- and outcome-specific for a general conclusion. [12]

What remains uncertain

  • whether reported sexual-health signals are clinically meaningful and reproducible;
  • which preparation, if any, performs better;
  • long-term safety and effectiveness;
  • effects in pregnancy, breastfeeding, adolescents or complex illness;
  • reliable effects on fertility, erectile dysfunction, menopause or daily function;
  • whether colour predicts a clinically useful response.

How might it work?

Maca contains macamides, macaenes, glucosinolates, sterols and other constituents. Laboratory work has proposed endocannabinoid, neurotransmitter, antioxidant and endocrine pathways. These explanations are mostly preclinical and do not show which constituent reaches an active concentration in people.

The healthy-men hormone data directly challenges a common mechanism claim: perceived sexual desire changed without a measured rise in circulating reproductive hormones. A plausible biochemical pathway is not a substitute for a clinical endpoint. [2], [3]

What are the risks and interactions?

Small trials and clinical summaries describe digestive upset, gastritis, headache, insomnia, cramps, mood changes and altered menstrual cycles. Short studies cannot estimate uncommon or delayed harms. LiverTox considers maca an unlikely cause of clinically apparent liver injury, while noting that the human safety evidence is limited. [7], [9]

Health Canada advises professional review during pregnancy or breastfeeding; with a blood-pressure condition or blood thinners at 0.6 g/day or more; and for sexual-health or mood claims when anxiety, depression or another psychological disorder is present. [1]

MSKCC advises caution with hormone-sensitive breast or uterine cancer because clinical safety is uncertain. This is a precaution, not proof that maca acts like estrogen in people. [7]

Laboratory interference

A case report described a woman using about one teaspoon of maca daily whose testosterone appeared extremely high on one immunoassay but not on other methods. The result normalized after maca stopped. This supports disclosing maca before hormone testing and resolving discordant results with the laboratory; it does not show that maca truly raised testosterone. [8]

Seek prompt care for severe allergy, fainting, persistent vomiting, severe abdominal pain, marked agitation, unusual bleeding, pregnancy-related concerns, or a laboratory result that conflicts with symptoms and other tests.

Legal status in the United States and Canada

In the United States, maca is sold as a dietary supplement. FDA does not approve supplements for safety and effectiveness before sale, and products cannot legally claim to treat sexual dysfunction, depression, infertility or another disease. [10]

In Canada, natural health products require a product licence and NPN. The current maca monograph defines eligible material, claims, amounts, duration wording and cautions. A licence does not prove that every maca product reproduces a trial. [1]

What should you monitor?

Record the species, plant part, preparation, colour or extract, lot, daily total and other ingredients. Choose one outcome tied to the reason for use, and set a review date rather than treating continued use as proof of benefit.

For sexual symptoms, record context that can confound interpretation: antidepressant changes, mood, sleep, relationship factors, pain and menopausal symptoms. A questionnaire trend cannot diagnose a hormonal or sexual disorder.

What happens when you stop?

The selected trials do not establish withdrawal, tapering or a required washout. Do not stop or change an antidepressant, anticoagulant, blood-pressure medicine or hormone treatment because maca was started or stopped without the prescriber.

How should it be stored?

Follow the product label. Keep it closed, dry, away from heat and children, and discard damaged or expired products. A traditional food history does not establish the shelf life of every extract.

How does maca compare with other approaches?

Sexual desire and function can be affected by medicines, depression, anxiety, relationship context, pain, menopause, vascular disease, diabetes and sleep. Medication review, counseling, pelvic or sexual-health care and evidence-based treatment address different causes.

Ginseng, tribulus, tongkat ali and DHEA have different identities, evidence and risks. There is no robust head-to-head evidence naming a universally best “libido” supplement, and stacking products prevents clear attribution.

What do public communities add?

Public discussions raise questions about powder taste, gelatinized products, colour, stimulation, digestion and perceived libido. They cannot authenticate the material, detect assay interference, estimate event rates or distinguish maca from medication and life changes. Anecdotes do not set the dose or efficacy estimate here.

Common questions

Does maca raise testosterone?

The controlled 12-week healthy-men study found no effect on testosterone or the other measured reproductive hormones. A separate case report describes assay interference, not a true hormone rise. [3], [8]

Does maca improve libido?

Small trials report self-reported signals in some populations. The evidence is limited, and it does not establish treatment for every cause of low desire or sexual dysfunction. [2], [4], [5], [11]

How long does maca take to work?

The healthy-men trial detected a desire difference from week 8, while other studies assessed 12-week outcomes. Those are study time points, not a guaranteed onset. [2]

Is 3 g per day the standard dose?

No. It is a total used in several studies and in some Canadian licensing conditions, with different materials and populations. It is not a universal regimen. [1], [2], [4], [5], [6]

Is gelatinized maca stronger?

Gelatinization changes the starch-rich material and may change tolerability. The selected evidence does not establish that it is universally stronger or more bioavailable.

Is black maca better than red or yellow maca?

No general superiority is established. One trial compared black and red preparations for selected outcomes, but it cannot support broad sex- or condition-based marketing rules. [6]

Can maca be used with antidepressants?

Small studies enrolled antidepressant users, but they do not clear all interactions or replace medication review. Do not change an antidepressant independently. [4], [5]

Should maca be stopped before a testosterone test?

Tell the ordering clinician and laboratory what you use. One case found assay-specific interference, but it cannot define a universal pause. The laboratory should decide how to investigate a discordant result. [8]

Glossary

Terms used in this guide.

Hypocotyl
The plant region between root and stem. Maca's swollen food and supplement material is often marketed simply as root.
Gelatinized maca
Maca processed with heat and moisture to alter or remove part of its starch; the word does not mean that gelatin was added.
ASEX
Arizona Sexual Experience Scale, a questionnaire used to assess several aspects of sexual function.
Assay interference
A substance or sample effect that changes a laboratory method's result without the same change being present in the body.
Titration
Changing an amount in planned steps. The selected maca trials do not establish a general titration method.
Preclinical
Research outside trials in people, such as cell or animal experiments.

How this guide was researched

This draft used Health Canada's current maca monograph, FDA supplement guidance, NCBI LiverTox, MSKCC's clinical summary, systematic reviews and primary human-study records. Searches covered botanical identity, preparation, sexual desire, antidepressant-associated dysfunction, reproductive hormones, colour comparisons, menopausal evidence, adverse effects and testosterone-assay interference.

Corrections to the legacy manuscript include removing a universal 1.5–3 g protocol, correcting the antidepressant pilot to a dose comparison without placebo, separating desire from hormone change, removing colour-specific superiority claims, removing a guaranteed cumulative onset, and treating the testosterone case as assay interference. Evidence was refreshed October 9, 2026.

How this guide was made

The source ledger stores population, preparation, amount, duration, outcomes, access and limitations. Primary studies support numeric rows; official sources frame licensing and safety. Draft status means scientific, French-parity, asset and rendered-page review remain separate gates.

Research method, access and remaining gaps

Current abstracts and full official pages were checked with emphasis on the exact material and measured outcome. Null hormone findings and the absence of placebo in the 2008 dose-comparison pilot were preserved.

Remaining gaps include independent preparation comparisons, long-term safety, larger sexual-function trials, pregnancy evidence, clinically tested interactions and a reliable assay-interference frequency. Community anecdotes were not used as efficacy proof.

Sources

Search the official guidance, reviews and human studies used for the material claims in this guide.

Showing 12 sources

  1. 01

    Natural Health Product Monograph: Maca ↗

    Official monograph

    Material, eligible claims, amounts, duration language and required cautions.

  2. 02

    Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. ↗

    Randomized placebo-controlled trial

    1.5 or 3 g/day for 12 weeks; self-reported desire signal from week 8.

  3. 03

    Effect of Lepidium meyenii (Maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. ↗

    Randomized placebo-controlled trial

    No effect on testosterone, estradiol, LH, FSH, prolactin or 17-hydroxyprogesterone.

  4. 04

    A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. ↗

    Randomized dose-comparison pilot

    1.5 versus 3 g/day for 12 weeks; no placebo, small sample and high attrition.

  5. 05

    A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women. ↗

    Randomized placebo-controlled trial

    1.5 g twice daily for 12 weeks; 45 randomized and 42 in modified intent-to-treat analysis; mean ASEX and MGH-SFQ changes were not significantly different.

  6. 06

    Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study. ↗

    Randomized placebo-controlled trial

    175 adults; 3 g/day for 12 weeks; self-perceived and altitude-related outcomes.

  7. 07

    Maca ↗

    Clinical herb summary

    Limited human evidence, adverse-effect reports, hormone-sensitive-condition caution and laboratory interference.

  8. 08

    First case report of testosterone assay-interference in a female taking maca (Lepidium meyenii). ↗

    Case report

    Assay-specific false testosterone elevation resolved after stopping maca.

  9. 09

    Maca ↗

    NIH safety record

    Limited trial safety and unlikely cause of clinically apparent liver injury.

  10. 10

    Questions and Answers on Dietary Supplements ↗

    Official guidance

    Premarket framework and medicine-interaction advice.

  11. 11

    Maca (L. meyenii) for improving sexual function: a systematic review. ↗

    Systematic review

    Limited evidence from a small number of heterogeneous trials.

  12. 12

    Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review. ↗

    Systematic review

    Few small trials and insufficient evidence for firm conclusions.